| ?? |
?? ?? |
CAS |
MF |
 |
CHRDL1 purified MaxPab rabbit polyclonal antibody (D01P) |
|
|
|
|
MYOC (Human) Matched Antibody Pair |
|
|
|
|
ANTI-FGF-2 |
|
|
|
|
DNAJA4 monoclonal antibody (M01), clone 4B4-1F2 |
|
|
|
|
ANTI-ELASTIN |
|
|
|
|
TK1 (Human) Matched Antibody Pair |
|
|
|
|
SMARCA2 monoclonal antibody (M06), clone 2D12 |
|
|
|
|
TNFSF13B monoclonal antibody (M01), clone 1C11 |
|
|
|
|
ACTN4 monoclonal antibody (M01), clone 4D10 |
|
|
|
|
GTF2H2 purified MaxPab mouse polyclonal antibody (B01P) |
|
|
|
|
Trastuzumab Deruxtecan |
1826843-81-5 |
N/A |
|
|
ANTI-PAD4 |
|
|
|
|
ANTI-GTPASE-ACTIVATING PROTEIN 1 |
|
|
|
|
Anti-MYF5 |
|
|
|
|
Anti-MYF5 |
|
|
|
|
Anti-RFTN2 |
|
|
|
|
Anti-LCE1A |
|
|
|
|
Anti-TCF12/HEB |
|
|
|
|
MMP-3(matrix metalloproteinase-3/Transin-1/SL-1/Stromelysin-1 precursor) |
|
|
|
|
Caspase-8 (pro Mch5) |
|
|
 |
C5a |
811418-15-2 |
C109H155N25O29S |
|
|
ADAM21 antibody |
|
|
|
|
Lyn
|
|
|
|
|
Calgranulin B (S100A9) Antibody |
|
|
|
|
Monoclonal Antibody to Deoxynivalenol (DON) |
|
|
|
|
Cd97 |
|
|
|
|
IgG Fraction of Monoclonal Mouse Anti-Biotin Antibody |
|
|
|
|
C9 neoantigen |
|
|
|
|
SIRL-1, Human, mAb 1A5, 100 μg |
|
|
|
|
ANTI-CYCLIN D2 |
|
|
|
|
TIMP-1, HUMAN |
|
|
|
|
Rabbit Anti-Albumin antibody |
|
|
|
|
ANTI-MCM2 |
|
|
|
|
melanocortin 5 receptor |
|
|
|
|
ELOA antibody |
|
|
|
|
F4/80 Antibody |
|
|
|
|
SUMO2/SUMO3/SUMO4 antibody |
|
|
|
|
CDK11A/CDK11B antibody |
|
|
|
|
ADGRE5 antibody |
|
|
|
|
TMSB10 antibody |
|
|
|
|
BIOXCELL Mouse NK1.1 Antibody |
|
|
|
|
Research Grade Anti-Influenza A virus HA/Hemagglutinin Broad-Neutralizing Antibody (CR9114) |
|
|
|
|
ANTI-HUMAN IGF BINDING PROTEIN-2 |
|
|
|
|
ANTI-HUMAN LIF |
|
|
|
|
Recombinant ANTI-IBA1 Antibody [EPR16589] - Mouse IGG1 (CHIMERIC) (AB283319) |
|
|
|
|
ANTI-MECP2 |
|
|
|
|
Mouse Monoclonal KSHVORF45 Antibody |
|
|
 |
RO5126766(CH5126766) |
946128-88-7 |
C21H18FN5O5S |
 |
I-CBP112 |
1640282-31-0 |
C27H36N2O5 |
 |
IWP-3 |
687561-60-0 |
C22H17FN4O2S3 |
 |
?????? |
1198300-79-6 |
C20H27N7O3S |
 |
HG-14-10-04 |
1356962-34-9 |
C29H34ClN7O |
 |
kb-NB77-78 |
1350622-33-1 |
C18H25NO3Si |
 |
NIBR189 |
1599432-08-2 |
C21H21BrN2O3 |
 |
VT-464 |
1610537-15-9 |
C18H17F4N3O3 |
 |
Gilteritinib |
1254053-43-4 |
C29H44N8O3 |
 |
Chitinase-IN-1 |
1579991-61-9 |
C18H16N4O2S |
 |
E-7449 |
1140964-99-3 |
C18H15N5O |
 |
ZLN-024 |
723249-01-2 |
C13H13BrN2OS |
 |
????IDH1-IN-1 |
1355326-21-4 |
C30H31FN4O2 |
 |
LP533401 hcl |
1040526-12-2 |
C27H23ClF4N4O3 |
 |
ML224 |
1338824-21-7 |
C31H31N3O5 |
 |
6-(?????)????-2,4(1H,3H)-?? |
83797-69-7 |
C12H21N3O2 |
 |
BLU9931 |
1538604-68-0 |
C26H22Cl2N4O3 |
![(E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine](/CAS/20180703/GIF/1232221-74-7.gif) |
(E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine |
1232221-74-7 |
C23H23N7O |
![6-amino-1,3-dimethyl-4-(4-(trifluoromethyl)phenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile](/CAS/20180703/GIF/1637739-82-2.gif) |
6-amino-1,3-dimethyl-4-(4-(trifluoromethyl)phenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile |
1637739-82-2 |
C16H13F3N4O |
 |
AF38469 |
1531634-31-7 |
C15H11F3N2O3 |
 |
IWP 4 |
686772-17-8 |
C23H20N4O3S3 |
 |
TH287 |
1609960-30-6 |
C11H10Cl2N4 |
![N′-[3,5-Bis(trifluoromethyl)phenyl]-N-[4-bromo-2-(2H-tetrazol-5-yl)phenyl]-thiourea](/CAS/20180713/GIF/956014-19-0.gif) |
N′-[3,5-Bis(trifluoromethyl)phenyl]-N-[4-bromo-2-(2H-tetrazol-5-yl)phenyl]-thiourea |
956014-19-0 |
C16H9BrF6N6S |
![3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone](/CAS/20180703/GIF/1290541-46-6.gif) |
3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone |
1290541-46-6 |
C22H17N3O |
![[4-(4-?????-3-???????)-3,5-????????]??????](/CAS/GIF/51-24-1.gif) |
[4-(4-?????-3-???????)-3,5-????????]?????? |
51-24-1 |
C14H9I3O4 |
 |
???????H |
83602-39-5 |
C62H111N11O12 |
 |
????? |
81486-22-8 |
C15H22N2O6 |
 |
YHO-13177 |
912287-56-0 |
C20H22N2O3S |
 |
SBI-0206965 |
1884220-36-3 |
C21H21BrN4O5 |
 |
AR-13324 (mesylate) |
1422144-42-0 |
C28H27N3O3.2CH4O3S |
 |
DC_05 |
890643-16-0 |
C25H25N3O |
 |
S1P1???III |
1324003-64-6 |
C21H16F3N3O3 |
 |
RO8994 |
1309684-94-3 |
C31H31Cl2FN4O4 |
 |
1-(1-(3-methoxyphenyl)-7-propoxyindolizin-3-yl)ethanone |
1693766-04-9 |
C20H21NO3 |
 |
RPT-835(alofanib) |
1612888-66-0 |
C19H15N3O6S |
 |
GSK-2256098 |
1224887-10-8 |
C20H23ClN6O2 |
 |
???? |
1353550-13-6 |
C26H26N6O2S |
 |
(S)-N-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide |
1448440-52-5 |
C17H14F2N4O2 |
 |
????? |
917393-39-6 |
C20H15FN4O2S |
 |
PLX8394 |
1393466-87-9 |
C25H21F3N6O3S |
 |
NS-018 |
1239358-86-1 |
C21H20FN7 |
 |
A-1331852 |
1430844-80-6 |
C38H38N6O3S |
 |
MI-136 |
1628316-74-4 |
C23H21F3N6S |
 |
PF-04929113 (Mesylate) |
1173111-67-5 |
C26H34F3N5O7S |
 |
PD-126055 free acid |
1316755-16-4 |
C32H29NO5 |
 |
CP21R7(CP21) |
125314-13-8 |
C19H15N3O2 |
 |
EAI-045 |
1942114-09-1 |
C19H14FN3O3S |
 |
I-BRD9 |
1714146-59-4 |
C22H22F3N3O3S2 |
 |
TA-02 |
1784751-19-4 |
C20H13F2N3 |
 |
GAL-021 |
1380341-99-0 |
C11H22N6O |
 |
CPI-455 |
1628208-23-0 |
C16H14N4O |
 |
EFT-508 |
1849590-01-7 |
C17H20N6O2 |
 |
LTX-315 |
1345407-05-7 |
C78H106N18O9 |